F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 2018.

J. A. Green, J. M. Kirwan, J. F. Tierney, P. Symonds, L. Fresco et al., Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, vol.358, pp.781-787, 2001.

A. Gadducci, S. Cosio, L. Cionini, and A. R. Genazzani, Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer, Anticancer Res, vol.21, pp.3525-3558, 2001.

J. Green, J. Kirwan, J. Tierney, C. Vale, P. Symonds et al., Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix, Cochrane Database Syst Rev, p.2225, 2005.

, Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)

, Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis, Cochrane Database Syst Rev, p.8285, 2010.

H. Lukka, H. Hirte, A. Fyles, G. Thomas, L. Elit et al., Concurrent cisplatinbased chemotherapy plus radiotherapy for cervical cancer--a meta-analysis, Clin Oncol (R Coll Radiol), vol.14, pp.203-215, 2002.

F. Kokka, A. Bryant, E. Brockbank, M. Powell, and D. Oram, Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer, Cochrane Database Syst Rev, p.10260, 2015.

S. Motton, G. Houvenaeghel, M. Delannes, D. Querleu, M. Soulé-tholy et al.,

, Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy, Int J Gynecol Cancer, vol.20, pp.268-75, 2010.

L. Sun, X. Sheng, J. Jiang, X. Li, N. Liu et al., Surgical morbidity and oncologic results after concurrent chemoradiation therapy for advanced cervical cancer, Int J Gynaecol Obstet, vol.125, pp.111-116, 2014.

P. J. Eifel, K. Winter, M. Morris, C. Levenback, P. W. Grigsby et al., Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01, J Clin Oncol, vol.22, pp.872-80, 2004.

R. Kobayashi, H. Yamashita, K. Okuma, K. Ohtomo, and K. Nakagawa, Details of recurrence sites after definitive radiation therapy for cervical cancer, J Gynecol Oncol, vol.27, p.16, 2016.

T. De-foucher, S. Bendifallah, L. Ouldamer, A. Bricou, V. Lavoue et al., Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group, Eur J Surg Oncol, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02468510

J. K. Schwarz, B. A. Siegel, F. Dehdashti, and P. W. Grigsby, Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer, Int J Radiat Oncol Biol Phys, vol.83, pp.185-90, 2012.

P. W. Grigsby, B. A. Siegel, F. Dehdashti, and D. G. Mutch, Posttherapy surveillance monitoring of cervical cancer by FDG-PET, Int J Radiat Oncol Biol Phys, vol.55, pp.907-920, 2003.

J. K. Schwarz, B. A. Siegel, F. Dehdashti, and P. W. Grigsby, Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma, JAMA, vol.298, pp.2289-95, 2007.

F. Liu, T. Su, C. Wang, A. Chao, H. Chou et al., Roles of posttherapy 18F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy, Eur J Nucl Med Mol Imaging, vol.45, pp.1197-204, 2018.

C. Kunos, T. Radivoyevitch, F. W. Abdul-karim, and P. Faulhaber, 18F-fluoro-2-deoxy-Dglucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response, Int J Gynecol Cancer, vol.21, pp.1117-1140, 2011.

S. Siva, D. S. Young, R. J. Hicks, R. J. Callahan, J. Bressel et al., 18 F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data, Eur J Nucl Med Mol Imaging, vol.42, pp.1825-1857, 2015.

S. Beriwal, N. Kannan, P. Sukumvanich, S. D. Richard, J. L. Kelley et al.,

, Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence, Gynecol Oncol, vol.127, pp.303-309, 2012.

V. S. Dhull, P. Sharma, D. N. Sharma, S. Maharjan, S. Kc et al., Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?, Int J Gynecol Cancer, vol.24, pp.312-332, 2014.

P. W. Grigsby, The prognostic value of PET and PET/CT in cervical cancer, Cancer Imaging, vol.8, pp.146-55, 2008.

S. Motton, D. Lapparent, T. Brenot-rossi, I. Buttarelli, M. et al., 18 Fluoro-2deoxy-d-glucose-positron emission tomography and locally advanced cervical cancer, Int J Gynecol Cancer, vol.19, pp.8-12, 2009.

G. Ferrandina, M. Petrillo, G. Restaino, V. Rufini, G. Macchia et al., Can surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?, Cancer, vol.118, pp.392-403, 2012.

K. Vandecasteele, L. Delrue, B. Lambert, A. Makar, K. Lambein et al., Value of magnetic resonance and 18 FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study, Int J Gynecol Cancer, vol.22, pp.630-637, 2012.

S. Pecorelli, Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

, Int J Gynaecol Obstet, vol.105, pp.103-107, 2009.

P. W. Grigsby, B. A. Siegel, F. Dehdashti, J. Rader, and I. Zoberi,

, fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome, J Clin Oncol, vol.22, pp.2167-71, 2004.